Lyophilized Injectable Drugs Market Size, Share, Growth Trends, and Analysis Forecast 2018-2026

Lyophilized Injectable Drugs Market:Overview

Transparency Market Research (TMR) has published a new report titled, "Lyophilized Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026". According to the report, the global lyophilized injectable drugs market was valued at US$ 2,300 Mn in 2017 and is projected to expand at a CAGR of 6.7% from 2018 to 2026.

Report Overview:

https://www.transparencymarketresearch.com/lyophilized-injectable-drugs-market.html

The global market is growing at a rapid pace due to rise in awareness and acceptance of lyophilized injectable drugs in proven applications and chronic medical conditions such as cardiac diseases and metabolic diseases.

Increase in usage of lyophilized injectable drugs in combination therapy is anticipated to augment the global lyophilized injectable drugs market.

The global lyophilized injectable drugs market has been segmented based on type of packaging, type of delivery, indication, and end-user. In terms of type of packaging, the market has been categorized into single-use vials, point-of-care reconstitution, specialty packaging, and others.

Request A Sample:

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37799

Based on type of delivery, the global lyophilized injectable drugs market has been classified into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices.

In terms of indication, the market has been divided into autoimmune diseases, infectious diseases, metabolic conditions, and others. Based on end-user, the market has been categorized into hospitals, ambulatory surgical centers, specialty clinics, and others. Moreover, lyophilized injectable drugs can be reconstituted easily and quickly, which is particularly valuable and useful for emergency antibiotics and vaccines that need to be administered quickly during causalities. Furthermore, lyophilized injectable drugs involve less cost compared to deep freezing and other conventional drug drying methods used for preservation of APIs and formulations.

Request for covid19 Impact Analysis:

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=37799

Development of Alternative Methods to Hamper Market Growth

Lyophilization of injectable drugs is an expensive process; hence, manufacturers strive to develop an alternative drying method to increase the shelf life of products, which can prove economical. However, such alternative processes need improvement in terms of retaining stability and biological or chemical activity of the substance.

Roche has developed a precipitation method as an alternative to lyophilization for the production of peptides, which enabled the company to reduce production costs, and deliver an effective, quality, and affordable product to customers. Advent of alternative methods during the forecast period is likely to hamper the growth of the global lyophilized injectable drugs market.

Specialty Packaging Segment to Grow at Rapid Pace

The report offers detailed segmentation of the global lyophilized injectable drugs market based on type of packaging, type of delivery, indication, and end-user. In terms of type of packaging, the single-use vials segment dominated the global market in 2017.

Increase in self administration of lyophilized injectables to treat various chronic conditions such as diabetes, rheumatoid arthritis, and migraine is projected to drive the single-use vials segment during the forecast period. The specialty packaging segment is expected to grow at a rapid pace from 2018 to 2026, as the segment offers packaging solutions such as pens, needle-free injectors, and two-part syringes that allow reconstitution in the device prior to injection.

North America Dominated Global Market

North America was the leading market for lyophilized injectable drugs in 2017 primarily due to extensive research & development activities, rapid acceptance of innovative technologies, and significant investments toward the development of health care infrastructure.

Additionally, presence of large number of manufacturing facilities in North America makes it the largest market for lyophilized injectable drugs. Moreover, large size of the contract manufacturing and services market in North America drives demand for lyophilized injectable drugs in the region. Asia Pacific presents significant opportunities in the health care sector, and was the third largest market in 2017.

The region accounted for large share of the global lyophilized injectable drugs market in 2017. Asia Pacific comprises emerging economies such as India, China, Indonesia, Vietnam, the Philippines, Malaysia, Singapore, and Thailand. These countries present large opportunities in the health care sector. The lyophilized injectable drugs market is expected to grow at a rapid pace in the region in the next few years due to untapped opportunities, improving health care infrastructure, and increasing availability of contract manufacturing and research services.

Braun Melsungen AG, Baxter, Becton, Dickinson and Company, and Mylan N.V. Lead the Market

The report also provides profiles of leading players operating in the global lyophilized injectable drugs market. These include B. Braun Melsungen AG, Baxter, Becton, Dickinson and Company, Mylan N.V., Schott AG, SHL Group, Vetter Pharma, CIRON Drugs & Pharmaceuticals Pvt. Ltd, and Jubilant HollisterStier.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/plasma-protein-therapeutics-market-to-advance-at-cagr-of-7-0-during-20192027--tmr-study-301479920.html

https://www.prnewswire.com/news-releases/c-arms-market-is-projected-to-expand-at-cagr-of-3-4-during-the-forecast-period-says-tmr-study-301483280.html

Contact

90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology.

These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

This release was published on openPR.